The role of vitamin D deficiency in the development of benign paroxysmal positional vertigo


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Background. Benign paroxysmal positional vertigo (BPPV) is the most common pathology of the peripheral part of the vestibular analyzer. Objective. Assessment of the effect of serum vitamin D levels on the occurrence and recurrence of BPPV episodes. Methods. From 2010 to 2022, a systematic review of original PubMed medical articles investigating the relationship between the onset and recurrence of BPPV and vitamin D levels was conducted. Results. It has been established that a low vitamin D level (<20 ng/ml) increases the risk of idiopathic BPPV due to an imbalance in the calcium metabolism in the inner ear. The degeneration of the otoliths that occurs in this condition leads to the idiopathic form of BPPV. A decrease in serum vitamin D <10 ng/ml leads to a relapsing course of the disease. Conclusion. Thus, patients with an established diagnosis of BPPV should be included in the diagnostic and treatment algorithm for determining the serum vitamin D level and prescribing vitamin D and calcium carbonate to prevent the recurrence of this condition.

Texto integral

Acesso é fechado

Sobre autores

K. Bgantseva

Russian Medical Academy of Continuous Professional Education

Email: bgantseva_kn@mail.ru
Moscow, Russia

S. Kosyakov

Russian Medical Academy of Continuous Professional Education

Moscow, Russia

Bibliografia

  1. Liao W.L., Chang T.P, Chen H.J., Kao C.H. Benign paroxysmal positional vertigo is associated with an increased risk of fracture: a population-based cohort study. J OrthopSports Phys Ther. 2015;45(5):406-12. doi: 10.2519/jospt.2015.5707.
  2. Lo M.H, Lin C.L., Chuang E., et al. Association of dementia in patients with benign paroxysmal positional vertigo. Acta Neurol Scand. 2017;135(2):197-203. doi: 10.1111/ ane.12581.
  3. Jeong S.H., Kim J.S., Shin J.W., et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol. 2013;260(3):832-38.
  4. Vibert D, Sans A., Kompis M., et al. Ultrastructural changes in otoconia of osteoporotic rats. Audiol. Neurootol. 2008;13(5):293-301.
  5. Jeong S.H., Kim J.S. Impaired calcium metabolism in benign paroxysmal positional vertigo: a topical review. J Neurol Phys Ther. 2019;43(Suppl. 2):S77-41. doi: 10.1097/NPT.0000000000000273.
  6. Thalmann R., Ignatova E., Kachar B., et al. Development and maintenance of otoconia: biochemical considerations. Ann N Y Acad Sci. 2001;942:162-78.
  7. Walther L.E., Blodow A., Buder J., Kniep R. Principles of calcite dissolution in human and artificial otoconia. PLoS One. 2014;9(7):e102516. doi: 10.1371/journal.pone.0102516.
  8. Yamauchi D, Raveendran N.N., Pondugula S.R., et al. Vitamin D upregulates expression of ECaC1 mRNA in semicircular canal. Biochem Biophys Res Commun. 2005;331(4):1353-57.
  9. Yamauchi D, Nakaya K., Raveendran N.N., et al. Expression of epithelial calcium transport system in rat cochlea and vestibular labyrinth. BMC Physiol. 2012;10:1-12.
  10. Yamauchi D, Nakaya K., Raveendran N.N., et al. Expression of epithelial calcium transport system in rat cochlea and vestibular labyrinth. BMC Physiol. 2012;:0:lo:2.
  11. Hughes I., Thalmann I., Thalmann R., Ornitz D. Mixing model systems: using zebrafish and mouse inner ear mutants and other organ systems to unravel the mystery of otoconial development. Brain Res. 2006;1091(1):58-74. Doi: 10.1016/j. brainres.2006.01.074.
  12. Chen J., Zhang S., Cui K., Liu C. Risk factors for benign paroxysmal positional vertigo recurrence: a systematic review and meta-analysis. J Neurol. 2020. doi: 10.1007/s0041 5-020-10175-0.
  13. Yang H., Gu H., Sun W., et al. Estradiol de ciency is a risk factor for idiopathic benign paroxysmal positional vertigo in postmenopausal female patients. Laryngoscope. 2018;128(4):948-53. https://doi.org/10.1002/lary.26628
  14. Wolf J.S., Boyev K.P, Manokey B.J., Mattox D.E. Success of the modified epley maneuver in treating benign paroxysmal positional vertigo. Laryngoscope. 1999;109(6):900-3. doi: 10.1097/00005537199906000-00011.
  15. Oh S.Y, Kim J.S., Choi K.D., et al. Switch to Semont maneuver is no better than repetition of Epley maneuver in treating refractory BPPV J Neurol. 2017;264(9):1892-98. doi: 10.1007/s0041 5-017-8580-2.
  16. Kim J.S., Oh S.Y., Lee S.H., et al. Randomized clinical trial for geotropic horizontal canal benign paroxysmal positional vertigo. Neurol. 2012;79(7):700-7. doi: 10.1212/WNL.0b013 e3182648b8b.
  17. Kim J.S., Oh S.Y, Lee S.H., et al. Randomized clinical trial for apogeotropic horizontal canal benign paroxysmal positional vertigo. Neurol. 2012;78(3):159-66. Doi: 10.1212/ WNL.0b013e31823fcd26.
  18. Yacovino D.A., Hain T.C., Gualtieri F. New therapeutic maneuver for anterior canal benign paroxysmal positional vertigo. J Neurol. 2009;256(11):1851-55. doi: 10.1007/s0041 5-009-5208-1.
  19. Gordon C.R., Gadoth N. Repeated vs single physical maneuver in benign paroxysmal positional vertigo. Acta Neurol Scand. 2004;110(3):166-69. doi: 10.1111/j.1600-0404.2004.00296.x
  20. Nunez R.A., Cass S.P, Furman J.M. Short- and long-term outcomes of canalith repositioning for benign paroxysmal positional vertigo. Otolaryngol Neck Surg. 2000;122(5):647-52. doi: 10.1067/ mhn.2000.105185.
  21. Jeong S.-H., Kim J.-S., Shin J.W., et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol. 2013;260(3):832-38. doi: 10.1007/s00415-012- 6712-2.
  22. Yu S., Liu F, Cheng Z., Wang Q. Association between osteoporosis and benign paroxysmal positional vertigo: a systematic review. BMC Neurol. 2014;14(1):110. doi: 10.1186/1471-2777-14110.
  23. Sarsitthithum K. , Wisupagan T, Kiatthanabumrung S., Jariengprasert C. The Association Between Serum Vitamin D Levels and Benign Paroxysmal Positional Vertigo. Ear Nose Throat J. 2021:1455613211008561. doi: 10.1177/01455613211008561.
  24. Yamanaka T, Shirota S., Sawai Y, et al. Osteoporosis as a risk factor for the recurrence of benign paroxysmal positional vertigo. Laryngoscope. 2013;:-3:-213-27.
  25. Talaat H.S., Abuhadied G., Talaat A.S., Abdelaal M.S. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol. 2015;272(9):2249-doi: 10.1007/s00405-014-7175-7.
  26. Rhim G.I. Serum vitamin D and recurrent benign paroxysmal positional vertigo. Laryngoscope Investig Otolaryngol. 2016;1(6):150-57. doi: 10.1002/lio2.75.
  27. Yang Y.S., Kang M.K. Relationship between bone mineral density and clinical features in women with idiopathic benign paroxysmal positional vertigo. Otol Neurotol. 2009;30:95-100.
  28. Kahraman S.S., Ozcan O., Arli C., et al. Calcium homeostasis during attack and remission in patients with idiopathic benign paroxysmal positional vertigo. Otol Neurotol. 2016;77:1788-92.
  29. Jeong S.H., Kim J.S., Kim H.J., et al. Prevention of benign paroxysmal positional vertigo with vitamin D supplementation: A randomized trial. Neurol. 2020;95(9):e1117-25. Doi: 10.1212/ WNL.0000000000010747.
  30. Talaat H.S., Kabel A.M., Khaliel L.H., et al. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx. 2016;47(7):277-41. doi: 10.1016/j.anl.2015.08.009.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2022